The Safety of Opioid Use in Chronic Obstructive Pulmonary Disease

The Safety of Opioid Use in Chronic Obstructive Pulmonary Disease is organized by Connect Educate Impact (CEI).

Initial Release Date: May 12, 2021
Planned Expiration Date: May 12, 2024  

Description:
May's Journal Club features a study discussing the association between transient opioid use and short-term respiratory exacerbation in patients with COPD. Learn the pros and cons related to clinical outcomes and safety, as discussed in the GOLD Guidelines and other documented trials.

Objectives:
Upon successful completion of this application-based course, pharmacists and pharmacy students should be able to:
• Discuss existing guidelines for the treatment of dyspnea among patients with Chronic Obstructive Pulmonary Disease (COPD)
• Evaluate the strengths of evidence from various existing studies
• Interpret the findings of Rong et al., 2019 and draw conclusions for clinical practice
• Describe the applicability, strengths, and limitations of case-crossover designs
• Identify avenues for future research to improve our understanding of opioid use among patients with COPD